Nanjing xingcan medical instrument co., LTD – Trademark Portfolio
Entity Type: 99
Nanjing xingcan medical instrument co., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEYARN. The owner is based in Nanjing.
Rm 237, 238, Bldg 25,No.86-Shuanggao Rd.
Nanjing 211300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Nanjing xingcan medical instrument co., LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Nanjing xingcan medical instrument co., LTD have?
Nanjing xingcan medical instrument co., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Nanjing xingcan medical instrument co., LTD file in?
Nanjing xingcan medical instrument co., LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 21 (Housewares), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Nanjing xingcan medical instrument co., LTD's most well-known trademarks?
Nanjing xingcan medical instrument co., LTD's registered trademark portfolio includes well-known marks such as MEYARN. These are among 1 currently registered trademark in the portfolio.
What is Nanjing xingcan medical instrument co., LTD's trademark registration success rate?
Nanjing xingcan medical instrument co., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.